Cargando…
MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia
Background: Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant disease characterized by hyperthyroxinemia without symptoms of thyrotoxicosis, due to a high affinity of mutant albumin for thyroxine. No report has described cortisol-albumin binding in FDH patient, and here we pre...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208649/ http://dx.doi.org/10.1210/jendso/bvaa046.409 |
_version_ | 1783530895439822848 |
---|---|
author | Chiba, Koki Kameda, Hiraku Nomoto, Hiroshi Cho, Kyu Yong Nakamura, Akinobu Jin, Shigeki Matoba, Kotaro Miyoshi, Hideaki Atsumi, Tatsuya |
author_facet | Chiba, Koki Kameda, Hiraku Nomoto, Hiroshi Cho, Kyu Yong Nakamura, Akinobu Jin, Shigeki Matoba, Kotaro Miyoshi, Hideaki Atsumi, Tatsuya |
author_sort | Chiba, Koki |
collection | PubMed |
description | Background: Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant disease characterized by hyperthyroxinemia without symptoms of thyrotoxicosis, due to a high affinity of mutant albumin for thyroxine. No report has described cortisol-albumin binding in FDH patient, and here we present a case of FDH presenting with false hypercortisolemia. Clinical Case: A 46-year man, previously diagnosed with FDH by genetic test (1), was pointed out hypercortisolemia with normal ACTH level (ACTH 64.7 pg/mL, Cortisol 34.7 μg/dL) during the investigation for Parkinson’s syndrome and referred to our department for further examination. Cortisol was 7.1 μg/dL at midnight, 14.9 μg/dL after low dose dexamethasone overnight test, and DDAVP test was positive. ACTH and cortisol responded to CRH load, although basal and peak cortisol levels were high (35.4 and 53.9 μg/dL, respectively). High dose dexamethasone overnight test showed suppressed ACTH and cortisol, and MRI showed no obvious pituitary adenoma. In spite of significant high cortisol level, no Cushing sign’s or metabolic abnormalities were observed and urinary free cortisol was within the normal range (30.7 μg/day), suggesting the presence of factors affecting the laboratory testing. We removed albumin from serum with immunoprecipitation using anti-albumin antibody and measured cortisol with LC-MS/MS. The decrease of cortisol was 4% in control serum but 38% in the patient serum after removing albumin, suggesting the binding rate of cortisol to mutant albumin in the patient was increased, leading to false hypercortisolemia. Conclusion: This is the first case demonstrating the false hypercortisolemia in a FDH patient. Clinicians should consider the possibility of the abnormal cortisol binding to albumin in differential diagnosis of hypercortisolemia with normal ACTH level. Reference: (1) Norio Wada, et al: A Novel Missense Mutation in Codon 218 of the Albumin Gene in a Distinct Phenotype of Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Kindred. Journal of Clinical Endocrinology and Metabolism 1997;82;3246–3250 |
format | Online Article Text |
id | pubmed-7208649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72086492020-05-13 MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia Chiba, Koki Kameda, Hiraku Nomoto, Hiroshi Cho, Kyu Yong Nakamura, Akinobu Jin, Shigeki Matoba, Kotaro Miyoshi, Hideaki Atsumi, Tatsuya J Endocr Soc Thyroid Background: Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant disease characterized by hyperthyroxinemia without symptoms of thyrotoxicosis, due to a high affinity of mutant albumin for thyroxine. No report has described cortisol-albumin binding in FDH patient, and here we present a case of FDH presenting with false hypercortisolemia. Clinical Case: A 46-year man, previously diagnosed with FDH by genetic test (1), was pointed out hypercortisolemia with normal ACTH level (ACTH 64.7 pg/mL, Cortisol 34.7 μg/dL) during the investigation for Parkinson’s syndrome and referred to our department for further examination. Cortisol was 7.1 μg/dL at midnight, 14.9 μg/dL after low dose dexamethasone overnight test, and DDAVP test was positive. ACTH and cortisol responded to CRH load, although basal and peak cortisol levels were high (35.4 and 53.9 μg/dL, respectively). High dose dexamethasone overnight test showed suppressed ACTH and cortisol, and MRI showed no obvious pituitary adenoma. In spite of significant high cortisol level, no Cushing sign’s or metabolic abnormalities were observed and urinary free cortisol was within the normal range (30.7 μg/day), suggesting the presence of factors affecting the laboratory testing. We removed albumin from serum with immunoprecipitation using anti-albumin antibody and measured cortisol with LC-MS/MS. The decrease of cortisol was 4% in control serum but 38% in the patient serum after removing albumin, suggesting the binding rate of cortisol to mutant albumin in the patient was increased, leading to false hypercortisolemia. Conclusion: This is the first case demonstrating the false hypercortisolemia in a FDH patient. Clinicians should consider the possibility of the abnormal cortisol binding to albumin in differential diagnosis of hypercortisolemia with normal ACTH level. Reference: (1) Norio Wada, et al: A Novel Missense Mutation in Codon 218 of the Albumin Gene in a Distinct Phenotype of Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Kindred. Journal of Clinical Endocrinology and Metabolism 1997;82;3246–3250 Oxford University Press 2020-05-08 /pmc/articles/PMC7208649/ http://dx.doi.org/10.1210/jendso/bvaa046.409 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Thyroid Chiba, Koki Kameda, Hiraku Nomoto, Hiroshi Cho, Kyu Yong Nakamura, Akinobu Jin, Shigeki Matoba, Kotaro Miyoshi, Hideaki Atsumi, Tatsuya MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia |
title | MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia |
title_full | MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia |
title_fullStr | MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia |
title_full_unstemmed | MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia |
title_short | MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia |
title_sort | mon-483 familial dysalbuminemic hyperthyroxinemia with false hypercortisolemia |
topic | Thyroid |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208649/ http://dx.doi.org/10.1210/jendso/bvaa046.409 |
work_keys_str_mv | AT chibakoki mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT kamedahiraku mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT nomotohiroshi mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT chokyuyong mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT nakamuraakinobu mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT jinshigeki mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT matobakotaro mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT miyoshihideaki mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia AT atsumitatsuya mon483familialdysalbuminemichyperthyroxinemiawithfalsehypercortisolemia |